PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor-Resistant Chronic Lymphocytic Leukemia.
Saved in:
| Title: | PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor-Resistant Chronic Lymphocytic Leukemia. |
|---|---|
| Authors: | Gordon BK; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Muhowski EM; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio., Singh J; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas., Ravikrishnan J; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Peris-Cuesta A; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas., Diaz Rohena D; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas., Sanchez JR; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas., Thangavadivel S; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Benrashid S; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., He A; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Marr AR; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Mitchell AD; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio., Urrutia JM; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Misra S; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Lai TH; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Yu L; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio., Walker BR; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Perry E; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Shukla SA; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas., Grieselhuber NR; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Rogers KA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Lapalombella R; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Blachly JS; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Kittai AS; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Bhat SA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio., Jain N; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas., Wierda WG; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas., Byrd JC; Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio., Niesman M; MingSight Pharmaceuticals Inc., San Diego, California., Zhang K; MingSight Pharmaceuticals Inc., San Diego, California., Sampath D; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas., Woyach JA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio. |
| Source: | Blood cancer discovery [Blood Cancer Discov] 2026 Jan 12; Vol. 7 (1), pp. 85-103. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41190953 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor-Resistant Chronic Lymphocytic Leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gordon+BK%22">Gordon BK</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Muhowski+EM%22">Muhowski EM</searchLink>; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Singh+J%22">Singh J</searchLink>; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Ravikrishnan+J%22">Ravikrishnan J</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Peris-Cuesta+A%22">Peris-Cuesta A</searchLink>; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Diaz+Rohena+D%22">Diaz Rohena D</searchLink>; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Sanchez+JR%22">Sanchez JR</searchLink>; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Thangavadivel+S%22">Thangavadivel S</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Benrashid+S%22">Benrashid S</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22He+A%22">He A</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Marr+AR%22">Marr AR</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Mitchell+AD%22">Mitchell AD</searchLink>; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Urrutia+JM%22">Urrutia JM</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Misra+S%22">Misra S</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Lai+TH%22">Lai TH</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Yu+L%22">Yu L</searchLink>; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Walker+BR%22">Walker BR</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Perry+E%22">Perry E</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Shukla+SA%22">Shukla SA</searchLink>; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Grieselhuber+NR%22">Grieselhuber NR</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Rogers+KA%22">Rogers KA</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Lapalombella+R%22">Lapalombella R</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Blachly+JS%22">Blachly JS</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Kittai+AS%22">Kittai AS</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Bhat+SA%22">Bhat SA</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Jain+N%22">Jain N</searchLink>; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Wierda+WG%22">Wierda WG</searchLink>; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Byrd+JC%22">Byrd JC</searchLink>; Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio.<br /><searchLink fieldCode="AU" term="%22Niesman+M%22">Niesman M</searchLink>; MingSight Pharmaceuticals Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Zhang+K%22">Zhang K</searchLink>; MingSight Pharmaceuticals Inc., San Diego, California.<br /><searchLink fieldCode="AU" term="%22Sampath+D%22">Sampath D</searchLink>; Division of Hematopoietic Biology and Malignancy, MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Woyach+JA%22">Woyach JA</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101764786%22">Blood cancer discovery</searchLink> [Blood Cancer Discov] 2026 Jan 12; Vol. 7 (1), pp. 85-103. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101764786 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2643-3249 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226433230%22">26433230 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer Discov <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41190953 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/2643-3230.BCD-25-0114 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 85 Titles: – TitleFull: PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor-Resistant Chronic Lymphocytic Leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gordon BK – PersonEntity: Name: NameFull: Muhowski EM – PersonEntity: Name: NameFull: Singh J – PersonEntity: Name: NameFull: Ravikrishnan J – PersonEntity: Name: NameFull: Peris-Cuesta A – PersonEntity: Name: NameFull: Diaz Rohena D – PersonEntity: Name: NameFull: Sanchez JR – PersonEntity: Name: NameFull: Thangavadivel S – PersonEntity: Name: NameFull: Benrashid S – PersonEntity: Name: NameFull: He A – PersonEntity: Name: NameFull: Marr AR – PersonEntity: Name: NameFull: Mitchell AD – PersonEntity: Name: NameFull: Urrutia JM – PersonEntity: Name: NameFull: Misra S – PersonEntity: Name: NameFull: Lai TH – PersonEntity: Name: NameFull: Yu L – PersonEntity: Name: NameFull: Walker BR – PersonEntity: Name: NameFull: Perry E – PersonEntity: Name: NameFull: Shukla SA – PersonEntity: Name: NameFull: Grieselhuber NR – PersonEntity: Name: NameFull: Rogers KA – PersonEntity: Name: NameFull: Lapalombella R – PersonEntity: Name: NameFull: Blachly JS – PersonEntity: Name: NameFull: Kittai AS – PersonEntity: Name: NameFull: Bhat SA – PersonEntity: Name: NameFull: Jain N – PersonEntity: Name: NameFull: Wierda WG – PersonEntity: Name: NameFull: Byrd JC – PersonEntity: Name: NameFull: Niesman M – PersonEntity: Name: NameFull: Zhang K – PersonEntity: Name: NameFull: Sampath D – PersonEntity: Name: NameFull: Woyach JA IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 01 Text: 2026 Jan 12 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2643-3249 Numbering: – Type: volume Value: 7 – Type: issue Value: 1 Titles: – TitleFull: Blood cancer discovery Type: main |
| ResultId | 1 |